Vivos Therapeutics to Participate at the Emerging Growth Conference
April 12, 2021 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., April 12, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative...
Vivos Therapeutics to Launch MyoCorrect Orofacial Myofunctional Therapy Service
March 30, 2021 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 30, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing...
Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update
March 25, 2021 16:05 ET
|
Vivos Therapeutics, Inc
Full Year Revenue Increase of 15% Management to Host Conference Call Today at 5:00 pm ET HIGHLANDS RANCH, Colo., March 25, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the...
Vivos Therapeutics to Participate at the Benzinga Biotech Small Cap Conference
March 22, 2021 16:05 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 22, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative...
Vivos Therapeutics Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for Thursday, March 25, 2021 at 5:00 pm ET
March 18, 2021 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 18, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative...
Vivos Therapeutics Announces the Opening of the First Pneusomnia Integrated Medical-Dental Sleep Center
March 08, 2021 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 08, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative...
Vivos Therapeutics to Participate in the Virtual 33rd Annual ROTH Conference on March 15-17, 2021
March 01, 2021 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., March 01, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative...
Vivos Therapeutics Launches VivoScore Diagnostic Technology for Home Sleep Apnea Testing in Children and Adults
February 16, 2021 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative...
Vivos Therapeutics Submits FDA 510(k) Application for the Vivos mmRNA Oral Appliance
February 02, 2021 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative...
Vivos Therapeutics Forms Clinical Advisory Board to Drive Further Growth of Next-Generation Obstructive Sleep Apnea Treatment Efforts
January 29, 2021 08:00 ET
|
Vivos Therapeutics, Inc
HIGHLANDS RANCH, Colo., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative...